Abstract. The thromboxane A 2 receptor (TP), one of the G protein-coupled receptors (GPCRs), consists of two splicing variants, TPα and TPβ, which differ in their C-terminal regions. In the present study, we investigated whether TPα and TPβ formed homo-or hetero-dimers and whether the dimerization changed the function of TP. The immunofluorescent analysis using human embryonic kidney (HEK) 293 cells expressing either FLAG-tagged TPα or TPβ showed that TPα is mainly distributed on plasma membranes and TPβ existed on plasma membranes and within the cells. Co-immunoprecipitation analysis using HEK293 cells expressing both TPα and TPβ showed that TPα and TPβ formed homo-and hetero-dimers. U46619, a TP agonist, caused phosphoinositide hydrolysis and elevation of [Ca 2+ ] i in a concentration-dependent manner in Chinese hamster ovary (CHO) cells expressing TPα or TPβ. The responses were observed to a greater extent in the cells expressing TPα than TPβ. In the cells expressing both TPα and TPβ, U46619-induced responses were observed to a lesser extent than in the cells expressing TPα alone. Furthermore, [ 3 H]SQ29548 binding showed that the level of the cell surface expression of TP was the following order: the cells expressing TPα > TPα and TPβ > TPβ. These results indicate that TPα and TPβ formed homo-and hetero-dimers, and TP-mediated signaling may be regulated by the hetero-dimer.
Introduction
Thromboxane A 2 , one of arachidonic acid metabolites, acts as a stimulator of platelets and a constrictor of smooth muscle cells (1) . Thromboxane A 2 receptor (TP) is a member of the G protein-coupled receptor (GPCR) family cloned as a prostanoid receptor for the first time (2) , and it is a representative G q -coupled receptor causing activation of phospholipase C (PLC) (3) . Recently, it is shown that TP has a role in immune systems, clarified by the analysis using TP-deficient mice (4) .
Similar to many GPCRs (5), human TP has splicing variants, which differ in their C-terminal tails. TPα, a first cloned isoform (2) (also called as placental type), consists of 343 amino acids, while TPβ (also named as endothelial type) consists of 407 amino acids (6) . Recent investigations demonstrated that many kinds of cells or tissues including endothelial cells expressed both TPα and TPβ (7) . There are some reports that mentioned the different characteristics of TPα and TPβ. Hirata et al. (8) showed that although both isoforms are coupled with the G q / PLC pathway, the stimulation of TPα results in elevation of cyclic AMP, but the stimulation of TPβ causes a decrease in cyclic AMP. Yukawa et al. (9) indicated that the two isoforms of TP were desensitized in different manners. It has been demonstrated that TPβ undergoes tonic (10) and agonist-induced (11) internalization. However, the difference between TPα and TPβ with respect to their physiological roles remains unclear. Moreover, it has not been identified how the function of the splicing variants are regulated.
Recently, it has been shown that various GPCRs form homo-and / or hetero-dimers (12, 13) . However, it is not clear why GPCRs form dimers. One of the roles of dimerization of GPCRs is suggested to be for maturation and intracellular translocation of GPCRs (14 -16) . Hetero-dimerization between GPCR splicing variants has been reported, such as vasopressin V 2 receptor, CCR5 calcitonin receptor, neurotensin NTS2 receptor, D 3 receptor, and α 1A adrenoceptor (17 -21) . On the other hand, some natural mutants of GPCRs retained themselves within the cells, most likely in the endoplasmic reticulum (ER) (17, 18, 20, 22) . It is assumed that there is a close relationship between dimerization and quality control of GPCRs. The decrease in cell surface receptor is assumed to result in reduction of the receptor-mediated signal transduction. Since thromboxane A 2 is unstable with a chemical half-life of 30 s, the expression level of cell surface TP is crucial to demonstrate the amplitude of receptor-mediated signal transduction.
In the present study, we investigated whether TPα and TPβ formed homo-and / or hetero-dimers. In addition, we investigated TP-mediated signal transduction was changed when TPα and TPβ were co-transfected into the cells.
Materials and Methods

Materials
U46619 was purchased from Cayman Chemical (Ann Arbor, MI, USA). The expression vector pEGFP-N1 and monoclonal anti-GFP antibody was from Clontech (Palo Alto, CA, USA), and anti-FLAG antibody was from Sigma (St. Louis, MO, USA). The expression vector pcDNA3.1 (+) and Lipofectamine 2000 was from Invitrogen (Merelbeke, Belgium). The HRP conjugated anti-mouse IgG and Enhanced Chemiluminescence reagent were from Amersham Biosciences (Piscataway, NJ, USA). FITC conjugated anti-mouse IgG was from Serotec (Oxford, UK). Alexa Fluor 594 conjugated antimouse IgG was from Molecular Probes (Eugene, OR, USA). G418 solution was purchased from Calbiochem (San Diego, CA, USA). Fura-2 AM was from Dojindo (Kumamoto).
Cell culture and transfection
Human embryonic kidney (HEK) 293 cells and Chinese hamster ovary (CHO) cells were grown in Dulbecco's modified Eagle's medium (DMEM; Nissui, Tokyo) containing 10% FCS, 50 unit / ml penicillin, and 50 µg/ ml streptomycin in a humidified incubator with a 5% CO 2 atmosphere at 37°C. Transfections were done with Lipofectamine 2000 according to the manufacturer's recommendations. HEK293 cells were stably transfected with FLAG-TPα or FLAG-TPβ, and cell clones were selected with 400 µg / ml G418.
Construction of plasmids
The cDNAs encoding wild type TPα (HPL / pBluescript) was generous gift from Dr. S. Narumiya (Kyoto University, Kyoto), and TPα/ pcDNA3.1(+) was constructed by inserting their cDNAs digested with BamHI / HincII into pcDNA3.1(+) digested with BamHI / EcoRV. Plasmid encoding wild type TPβ was constructed by inserting two fragments into pcDNA3.1(+). The first fragment was obtained by digestion of HPL / pBluescript at the EcoRI / BsiHKAI site. The second fragment was obtained by RT-PCR using RNA from 1321N1 human astrocytoma cells with a sense primer (5'-AAAGTCGACAAGAGCCGTGCTCAGGC GTCTCAGCC-3') and an antisense primer (5'-TTGCG GCCGCTCAATCCTTTCTGGACAGAGCCTTCCC-3'), and the fragment was digested with BsiHKAI / NotI. Resulting cDNA fragments were cloned into pcDNA3.1(+) digested with EcoRI/ NotI together. FLAG-tagged and HA-tagged clones of TPα or TPβ were constructed as described before (11) . For construction of GFP-tagged TPα, the cDNA encoding TPα was subcloned into pEGFP-N1 at NheI / PstI site. GFPtagged TPβ was constructed by RT-PCR with a sense primer (5'-GGAGATGATGGCTCAGCTCCTG-3') and an antisense primer (5'-AAACTGCAGATCCTTTCTG GACAGAGCCTTCC-3') including the BlpI / PstI site and ligated into GFP-tagged TPα plasmid digested with BlpI / PstI. All PCR was performed by pfu turbo DNA polymerase (Stratagene, Tokyo) and the DNA sequence was confirmed by ABI310 (Applied Biosystems, Foster City, CA, USA).
Immunofluorescence
HEK293 cells stably expressing FLAG-TPα or TPβ were grown on coverglasses coated with 100 µg/ ml poly-L-lysine (Sigma) and fixed with 4% paraformaldehyde / PBS. After washing the cells twice with PBS, the cells were blocked and permeabilized with 0.05% Triton X-100 / 5% nonfat milk / PBS for 30 min at 37°C. Then, the cells were incubated with anti-FLAG M1 antibody (1:50) for 1 h and incubated with FITC conjugated anti-mouse IgG (1:40) for 1 h. The cells were washed 5 times with PBS and the fluorescence was analyzed by OLYMPUS microscopy (Olympus, Tokyo).
Co-immunoprecipitaion and Western blot analysis
HEK293 cells were co-transfected with the indicated plasmid mixtures. Empty pcDNA3.1(+) vector or pEGFP-N1 vector was always added in order to transfect a constant amount of plasmid DNA. At 48-h posttransfection, the cells were washed with TBS (20 mM Tris-HCl, pH 7.4, 150 mM NaCl) and incubated in lysis buffer (20 mM Tris-HCl, pH 7.4, 150 mM NaCl, 1% NP40, 0.1% SDS, and 0.5% sodium deoxycholate) for 30 min at 4°C. Lysates were centrifuged in 17,400 × g for 10 min at 4°C, and the supernatants were incubated with anti-FLAG M2 agarose (Sigma) for 1 h at 4°C. Following incubation, the immunoabsorbents were washed three times with lysis buffer and once in TBS. The proteins were dissolved in SDS-sample buffer and subjected to 11% SDS-PAGE. After transfer onto PVDF membranes, the immunecomplexes were detected with anti-HA or anti-GFP antibody followed with HRP conjugated anti-mouse IgG and detected with ECL detection reagents.
Confocal microscopy
HEK293 cells transfected with both GFP-TPα and FLAG-TPβ were grown on coverglasses coated with 100 µg / ml poly-L-lysine and fixed with 4% paraformaldehyde / PBS. After washing the cells twice with PBS, the cells were blocked and permeabilized with 0.05% Triton X-100 / 5% nonfat milk / PBS for 30 min at 37°C. Then, the cells were incubated with anti-FLAG M2 antibody (1:500) for 1 h and incubated with Alexa Fluor 594 conjugated anti-mouse IgG (1:500) for 1 h. The cells were washed 5 times with PBS and the fluorescence was analyzed by Leica confocal microscopy (Leica, Wetzlar, Germany).
Assay of inositol phosphates
CHO cells were transiently transfected with the indicated plasmid, and then empty vector was always added to be transfected equal amount of DNA. Twentyfour hours after transfection, the cells were labeled with myo-[ 3 H]inositol at 2 µCi / mL for another 24 h. After labeling, cells were washed twice with modified Tyrode's solution (10 mM HEPES, 137 mM NaCl, 2.7 mM KCl, 1.0 mM MgCl 2 , 0.18 mM CaCl 2 , and 5.6 mM glucose, pH 7.4) and preincubated in the 10 mM LiCl containing Tyrode's solution at 37°C for 10 min. The cells were incubated with U46619 for 20 min and the reaction was terminated by addition of 5% trichloroacetic acid (TCA) after aspiration of the solution. The TCA extract was washed three times with diethyl ether to remove TCA, and the remained diethyl ether was removed by maintaining the samples at 47°C. Total [ 3 H]inositol phosphates were separated by an anion exchange column (AG1X-8, formate form) and their radioactivities were measured. For determining total [ 3 H]phosphoinositides, the TCA precipitate was dissolved in 1 N NaOH, and the radioactivity was measured after neutralization with 1 N HCl.
Determination of intracellular free calcium concentration ([Ca
] i ) was measured as described before (23) . Briefly, the CHO cells expressing TPα, TPβ, or both were incubated with 1 µM fura 2-AM for 15 min at 37°C and then washed with modified Tyrode's solution. Intracellular Ca 2+ were monitored by a spectrofluorometer (F-2000; Hitachi, Tokyo).
Receptor binding assay
Membranes were prepared as described previously (24) . Briefly, CHO cells transiently transfected with the indicated plasmids were washed twice with PBS and incubated with hypotonic buffer (10 mM HEPES and 10 mM EDTA, pH 7.4) for 10 min at 4°C. The buffer was aspirated and the cells were scraped. The crude membranes were obtained by centrifugation at 17400 × g for 10 min and washed twice with the hypotonic buffer. The membrane proteins were determined by the DC protein assay (Bio-Rad, Hercules, CA, USA).
The 200 µg membranes per tube were incubated in the binding buffer (10 mM HEPES and 5 mM MgCl 2 , pH 7.4) with 20 nM [
3 H]SQ29548 for 30 min at 37°C. The reaction was stopped by addition of ice-cold washing buffer (10 mM Tris-HCl, 140 mM NaCl, pH 7.4) and filtrated with a GC50 filter paper (Advantec, Tokyo). After an additional two washes with washing buffer, the radioactivity in the filter paper was counted. Specific binding was obtained by subtracting nonspecific binding in the presence of 10 µM SQ29548.
Statistical analysis of data
All data were expressed as the mean ± S.E.M. Statistical significance was determined with two-way ANOVA or Tukey's post-hoc test for multiple comparisons. P<0.05 was considered to be significant.
Results
The cell surface expression of TPα and TPβ
To examine the subcellular localization of TPα and TPβ, we generated HEK293 cells stably expressing either FLAG-TPα or FLAG-TPβ. In these cells, the FLAG-TPα fluorescence was only found at the cell surface, while FLAG-TPβ fluorescence was found at both the cell surface and inside of the cell (Fig. 1) .
Dimerization of TPα and TPβ
To determine whether TPα and TPβ dimerize and/ or oligomerize, we performed co-immunoprecipitation analysis using HEK293 cells expressing FLAG-tagged TPα or TPβ with HA-tagged TPα or TPβ. The immuno- precipitated materials with anti-FLAG antibody were subjected to SDS-PAGE and blotted with anti-HA antibody ( Fig. 2A) . The immunoprecipitated proteins obtained from the cells expressing FLAG-TPα and HA-TPα showed HA-TPα of 27 -33 and 50 -65 kDa, demonstrating that TPα forms a homo-dimer (lane 1). Lane 2 showed 33 -40 and 50 -67 kDa bands of HA-TPβ, demonstrating that TPα and TPβ form a hetero-dimer. Lane 3 showed bands of HA-TPα correspondingly to the result of lane 2. The immunoprecipitated proteins obtained from the cells expressing FLAG-TPβ and HA-TPβ showed a band of HA-TPβ, showing that TPβ forms homo-dimers (lane 4). In the cases using GFP-tagged TPs instead of HA-tagged TPs (Fig. 2B) , we found GFP-TPα (lane 1, 2: 35 -52 kDa, 70 -83 kDa) or GFP-TPβ (lane 3, 4: 40 -58 kDa, 75 -85 kDa) in the immune complexes, respectively. These results suggest that TPα and TPβ dimerize or oligomerize in a homo-and hetero-fashion.
Co-localization of TPα and TPβ
We examined intracellular localization of TPα and TPβ immunohistochemistry using confocal microscopy (Fig. 3) . After GFP-TPα and FLAG-TPβ were coexpressed in HEK293 cells, the cells were immunolabeled with anti-FLAG M2 antibody and Alaxa Fluor 594-conjugated anti-mouse IgG to visualize TPβ. GFP-TPα and FLAG-TPβ were localized on plasma membranes and intracellular regions. A merged photograph indicated that TPα and TPβ were co-localized in part on plasma membranes and intracellular regions (Fig. 3) .
Effect of co-expression of TPα and TPβ on U46619-induced phosphoinositide hydrolysis and [Ca
We examined whether the hetero-dimerization of TPα and TPβ changed the function of TP. U46619, a TP agonist, caused the accumulation of inositol phosphates (IPs) in a concentration-dependent manner in both CHO cells expressing GFP-TPα and FLAG-TPβ (Fig. 4A) . However, the accumulated IPs were greater in the cells expressing TPα than TPβ. In the cells expressing both GFP-TPα and FLAG-TPβ, U46619 caused IP accumulation to a smaller extent than in the cells expressing GFP-TPα alone (Fig. 4A) . The expressed level of GFP-TPα was almost the same between the cells expressing GFP-TPα alone and GFP-TPα with FLAG-TPβ (Fig. 4B) . The decrease of U46619-induced phosphoinositide hydrolysis in the cells co-expressing TPα and TPβ was also observed as well as both GFP-TPα and FLAG-TPβ in the cells expressing both wild-type TPα and TPβ (data not shown).
Next, [Ca
2+
] i was measured to confirm the results of phosphoinositide hydrolysis. U46619-induced increase in [Ca
] i was greater in the cells expressing TPα than TPβ, consistent with the result of phosphoinositide hydrolysis. In the cells co-expressing both TPα and TPβ, U46619 increased [Ca 2+ ] i to a smaller extent than in the cells expressing TPα alone (Fig. 4C) . These findings indicate that the hetero-dimerization of TPα and TPβ reduced TP-mediated signal transduction, and a possible mechanism is suggested to be that the cell surface expression of TPα is reduced under co-expression of TPα and TPβ.
Reduction of the cell surface TPα by co-expression with TPβ
Considering the fact that TPα and TPβ forms heterodimers and that U46619-induced signal transduction is decreased in the cells expressing TPα and TPβ, the cell surface expression of TP might be reduced under the condition of co-expression of TPα and TPβ. To address this question, we performed a receptor binding assay using (Fig. 5) . Moreover, the membranes expressing both TPα and TPβ showed a lower level of TP than the membranes expressing TPα alone.
Discussion
The present study demonstrated that TPα and TPβ formed homo-and hetero-dimers and that the heterodimer of TPα and TPβ might regulate TP-mediated signaling. There is accumulating evidence that various members of GPCRs form homo-and hetero-dimers (12) . Although the physiological role of GPCR homodimerization has not be fully understood yet, some reports suggested a relationship between the heterodimerization of GPCRs and their quality control. For example, it has been shown that α1D and α1B adrenoceptors form hetero-dimers and that the α1B adrenoceptor is essential for the cell surface expression of α1D adrenoceptor (15) . Metabotropic GABA B1 receptor forms hetero-dimers with GABA B2 receptor and the hetero-dimerization masks an ER retention signal of the C-terminus of GABA B1 receptor. Consequently, the GABA B1 receptor could translocate to the plasma membrane (25) .
In contrast to the cases of α1 adrenoceptor and GABA B receptor, some natural splicing variants of GPCRs cause receptor retention within the cells, most likely in the ER, such as CCR5 receptor, vasopressin V 2 receptor, and D 3 dopamine receptor (17, 18, 20) . In these cases, the receptor-mediated signals were weakened in the presence of the corresponding splicing variant. For example, cell surface expression of calcitonin receptor was abrogated by its alternative splicing variant, followed by decrease in calcitonininduced cyclic AMP elevation and phosphorylation of ERK (22) . Such a functional regulation was also shown in other GPCRs such as vasopressin V 2 receptor (17). One possible role of the splicing variant of GPCRs is, therefore, thought to decrease its cell surface expression and to decline its signal as an apparent dominant-negative mutant.
It is uncertain where GPCRs form dimers. The dimer could be formed on the plasma membrane or inside of the cells, for example, ER, an organelle that has a crucial role in the quality control of protein synthesis (26) . TP has been reported to have N-glycosylation sites at its Nterminus (27) , and the glycosylation was believed to be necessary for its cell surface expression. The glycosylated TPα and TPβ showed a broad protein band of 55 -70 kDa in SDS-PAGE, and the deglycosylated forms of TPα and TPβ were 28 kDa and 32.5 kDa, respectively (28) . We have shown in Fig. 2 that immunoprecipitated proteins contain both non-glycosylated and glycosylated TPs, and the major TP is a nonglycosylated form. Figure 3 shows that TPα and TPβ co-localize on plasma membranes and intracellular regions. Considering these results, the dimerization of TPα and TPβ may have occurred principally before the glycosylation, most likely in the ER; and TPβ, which tends to be retained in an intracellular compartment, holds TPα within the cell according to their heterodimerization.
It is important whether dimers were formed constitutively or in an agonist-dependent manner. Several reports showed that the dimerization occurred in an agonist-dependent manner (29, 30) , while some reports showed that it was constitutive (22, 31) . In our preliminary experiments of co-immunoprecipitation, 1 µM U46619 did not affect the formation of the heterodimer of TPα and TPβ until 20 min (M. Sasaki and N. Nakahata, unpublished observation). Thus, it is suggested that TPα and TPβ form a hetero-dimer in the ER rather than in the plasma membrane, and TPβ may inhibit the cell surface expression of TPα, probably through their hetero-dimerization. Physiological role of hetero-dimerization between TPα and TPβ probably involves the quality control of newly synthesized TPs and the translocating of TPs toward the plasma membrane. Because the immunoprecipitated complex may contain other proteins in addition to TPα and TPβ, we cannot exclude a possibility that TPα and TPβ are associated indirectly. Thus the further study was necessary to clarify the direct association of TPα and TPβ on the molecular level.
In the present study, we demonstrated that TPα and TPβ formed hetero-dimers, and the formation of hetero-dimers resulted in the reduction of TP-mediated signaling through the decrease in the cell surface expression of TP. In other words, the proportion of expressed TPα and TPβ is important for eliciting the function of TP. Thus a further study would be necessary to determine the mechanism regulating the proportion of splicing variants to clarify the molecular regulatory mechanism of TP-mediated signal transduction.
